Dishman Pharmaceuticals & Chemicals Ltd.[Merged] - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 16	Mar ' 15	Mar ' 14	Mar ' 13	Mar ' 12

Sources of funds

Owner's fund

Equity share capital

16.14

16.14

16.14

16.14

16.14

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

893.68

818.61

779.26

709.28

657.10

Loan funds

Secured loans

433.05

411.57

367.35

391.57

393.96

Unsecured loans

109.46

93.98

49.11

63.43

35.73

Total

1,452.33

1,340.30

1,211.86

1,180.42

1,102.93

Uses of funds

Fixed assets

Gross block

991.40

971.74

694.61

874.81

630.40

Less : revaluation reserve

1.68

1.68

1.68

-

1.71

Less : accumulated depreciation

321.76

278.13

-

192.26

160.08

Net block

667.96

691.94

692.94

682.55

468.61

Capital work-in-progress

22.14

10.15

9.86

48.79

257.34

Investments

250.78

223.36

187.06

187.06

187.06

Net current assets

Current assets, loans & advances

771.90

766.13

654.05

576.62

528.27

Less : current liabilities & provisions

260.45

351.28

332.05

314.60

338.36

Total net current assets

511.45

414.85

322.01

262.02

189.91

Miscellaneous expenses not written

-

-

-

-

-

Total

1,452.33

1,340.30

1,211.86

1,180.42

1,102.93

Notes:

Book value of unquoted investments

250.77

223.35

187.05

187.05

187.05

Market value of quoted investments

0.02

0.04

0.05

0.06

0.08

Contingent liabilities

426.76

384.94

474.68

488.92

567.74

Number of equity sharesoutstanding (Lacs)

806.97

806.97

806.97

806.97

806.97